Photo: Courtesy of Eli Lilly

18 July 2017Americas

Eli Lilly settles Cialis patent litigation with generic makers

Eli Lilly has entered into a settlement agreement with generic companies Teva Pharmaceuticals and Watson Laboratories to resolve pending patent litigation over its drug Cialis (tadalafil).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

Eli Lilly tries to halt another Cialis generic

10 April 2018 Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis.

More on this story

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

Eli Lilly tries to halt another Cialis generic

10 April 2018 Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis.

More on this story

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

Eli Lilly tries to halt another Cialis generic

10 April 2018 Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’

Powell Gilbert launches Düsseldorf office with leading patent litigator

Startups toolkit: Why investors want more than patents

J&J fends off generic schizophrenia drug bids

Kilpatrick adds ‘seasoned litigator’ as trademark partner

WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond

Startup challenges rival over brain monitoring tech at ITC

UKIPO rejects Boehringer’s SPC for horse inhaler